feed,title,long_url,short_url
SeekingAlpha,Clovis starts enrollment of phase 1/2 trial for candidate to treat tumors,https://seekingalpha.com/news/3709042,
SeekingAlpha,Enrollment underway in Editas Medicine's pediatric cohort of EDIT-101 study in inherited retinal disorder,https://seekingalpha.com/news/3709045,
SeekingAlpha,Arrowhead posts positive data from early-stage NASH trial,https://seekingalpha.com/news/3709044,
SeekingAlpha,HSBC points to 80% upside on Thai Beverage,https://seekingalpha.com/news/3709043,
